Labshake search
Citations for Tocris :
1 - 50 of 369 citations for 6 HYDROXYFLAVONE β D GLUCOSIDE since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... 6-N,N-Diethyl-β-γ-dibromomethylene-D-adenosine-5′-triphosphate (ARL 67156; Tocris, 1283) was perfused through the probe at concentrations of 1 mM ...
-
bioRxiv - Cancer Biology 2019Quote: ... ARL 67156 Trisodium Salt (6-N,N-Diethyl-D-β,γ-dibromomethyleneATP trisodium salt) and POM 1(Sodium metatungstate) were obtained from Tocris Bioscience ...
-
bioRxiv - Neuroscience 2022Quote: ... the medium was replaced with HBSS containing 6-N,N-Diethyl-β-γ-dibromomethylene-D-adenosine-5′-triphosphate (ARL 67156; Tocris, 1283) at a concentration of 100 μM ...
-
bioRxiv - Immunology 2021Quote: ... TGF-β (5ng/ml; carrier-free; Tocris R&D Systems), anti-IFNγ antibody (2 ug/ml ...
-
bioRxiv - Immunology 2021Quote: ... TGF-β (30 ng/ml; carrier-free; Tocris R&D Systems), IL-6 (30 ng/ml ...
-
bioRxiv - Immunology 2021Quote: ... IL-6 (30 ng/ml; carrier-free; Tocris R&D Systems), IL-1β (10 ng/ml ...
-
bioRxiv - Neuroscience 2020Quote: ... β-funaltrexamine (β-FNA; an irreversible antagonist of the MORs) was obtained from Tocris (Bristol, UK). Stock solutions of β-FNA were prepared by dissolving the compound in the correct volume of distilled water to obtain 13.6 mM concentration of β-FNA ...
-
bioRxiv - Neuroscience 2019Quote: ... D- (-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) and STR were added to the bath solution to block AMPA ...
-
bioRxiv - Neuroscience 2024Quote: ... D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris), tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2024Quote: 6-hydroxydopamine (Tocris) injections were performed in WT mice at 8-9 weeks of age ...
-
bioRxiv - Neuroscience 2020Quote: ... Dihydro-β-erythroidine (DhβE, 3 μM, Tocris) was used to block β2 containing nicotinic receptors ...
-
bioRxiv - Neuroscience 2021Quote: ... Dihydro-β-erythroidine hydrobromide (DhβE; 1μM, Tocris) to block type 2 nicotinic receptors (containing β2-subunits) ...
-
bioRxiv - Developmental Biology 2023Quote: ... 8nM β-estradiol (50-28-2, Tocris) and 200ng/mL progesterone (P0130 ...
-
bioRxiv - Immunology 2023Quote: ... TGF-β inhibitor A83-01 (500nM, Tocris), p38 inhibitor SB202190 (10µM ...
-
bioRxiv - Neuroscience 2022Quote: ... 50 D-2-amino-5-phosphonopentanoic acid (D-APV) (Tocris), and 10 gabazine (Sigma) ...
-
bioRxiv - Neuroscience 2020Quote: ... and D(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) was prepared as 50 mM stocks dissolved in 30% 1 M NaOH ...
-
bioRxiv - Neuroscience 2019Quote: ... 200µM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris). All these compounds were applied in the recording chamber for at least 10 minutes before continuing measurements ...
-
bioRxiv - Neuroscience 2021Quote: ... and d-2-amino-5-phosphonopentanoic acid (D-AP5) (Tocris). Drugs were prepared as concentrated stock solutions and were diluted in ACSF on the day of the experiment.
-
bioRxiv - Neuroscience 2020Quote: ... 0.9% w/v) and 6-OHDA HCl powder (6-hydroxydopamine hydrochloride from Sigma or 6-OHDA hydrobromide from Tocris) was then dissolved to produce a final 6-OHDA concentration of 4.44 mg/ml ...
-
bioRxiv - Neuroscience 2020Quote: ... D-AP5 (Tocris) at 50 μM ...
-
bioRxiv - Cell Biology 2021Quote: ... Actinomycin D (Tocris) was added to a final concentration of 100 μg/ml ...
-
bioRxiv - Neuroscience 2021Quote: ... D-AP5 (Tocris) and NiCl2 (Sigma ...
-
bioRxiv - Genomics 2022Quote: ... and 100μM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5, Tocris) overnight to reduce endogenous neuronal activity prior to stimulation ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) (Tocris), 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX ...
-
bioRxiv - Neuroscience 2022Quote: ... and 50 mM D-AP5 (D-2-amino-5-phosphonovalerate, Tocris) to block AMPA and NMDA receptors ...
-
bioRxiv - Neuroscience 2024Quote: ... and 50µM D-AP5 (D-2-amino-5-phosphonovalerate, Tocris 0106). Neurons were voltage clamped at -70mV ...
-
bioRxiv - Neuroscience 2024Quote: ... and D-2-amino-5-phosphonopetanoate (D-AP5, 50 μM; Tocris) were added to inhibit GABAergic or glutamatergic synaptic transmission ...
-
bioRxiv - Biochemistry 2024Quote: ... 25 μM d-(−)-2-amino-5-phosphonovaleric acid (D-AP5, Tocris), and 100 μM picrotoxin (Nacalai Tesque ...
-
bioRxiv - Developmental Biology 2021Quote: ... CHIR99021 (6 μM; Tocris), FGF2 (20 ng/mL ...
-
bioRxiv - Neuroscience 2022Quote: ... Di-hydro-β-erythroidine (DHβE, 8 μM, Tocris) was added to the perfusion system immediately before imaging to block spontaneous retinal waves that would otherwise interfere with measurements of light responses ...
-
bioRxiv - Biophysics 2023Quote: ... 3,4-methylenedioxy-β-nitrostyrene (MNS) was from Tocris Biosciences (Minneapolis ...
-
bioRxiv - Immunology 2024Quote: ... TGF-β inhibitor A83-01 (500 nM, Tocris), p38 inhibitor SB202190 (10 µM ...
-
bioRxiv - Cell Biology 2019Quote: ... and 50µM D-(-)-2-amino-5-phosphonopentanoic (D-AP5 or APV; Tocris) buffered to pH 7.4 at 37°C ...
-
bioRxiv - Neuroscience 2022Quote: ... D-2-Amino-5-phosphonopentanoic acid (D-AP5, 25 μM; Tocris #0106). These were stored as stock aliquots and diluted in fresh aCSF to their final concentration the day of recording ...
-
bioRxiv - Neuroscience 2019Quote: ... 25μM D-AP5 (Tocris) and 20μM Gabazine (Sigma ...
-
bioRxiv - Neuroscience 2019Quote: ... All drugs were purchased from Sigma or R&D (Tocris).
-
bioRxiv - Neuroscience 2020Quote: ... D-AP5 (50μM, Tocris) or DL-AP5 (25μM ...
-
bioRxiv - Neuroscience 2022Quote: ... D-AP5 (#0106, Tocris), PPADS (ab12009 ...
-
bioRxiv - Neuroscience 2022Quote: D-AP5 (Tocris, USA) was suspended in water as 50 mM stock solution ...
-
bioRxiv - Neuroscience 2024Quote: ... D-AP-550μM (Tocris), and TTX 1 μM (Tocris ...
-
bioRxiv - Neuroscience 2019Quote: ... and 50 µM D-2-amino-5-phosphonovaleric acid (D-AP-5; Tocris) to isolate synaptic inhibitory transmission ...
-
bioRxiv - Cell Biology 2022Quote: Cells were treated with 0.05 µg/ml Actinomycin D (Act D) (1229, Tocris) dissolved in DMSO in a complete medium for 0.5 or 2 h at 37°C ...
-
bioRxiv - Neuroscience 2023Quote: ... and 100 μM D-(−)-2-Amino-5-phosphonopentanoic acid (D-APV, Tocris, 0106) to block glutamatergic inputs ...
-
bioRxiv - Neuroscience 2023Quote: ... CNQX and D(−)-2-Amino-5-phosphonopentanoic acid (D-AP5) were from Tocris Biosciences ...
-
bioRxiv - Neuroscience 2023Quote: ... D-2-amino-5-phosphonopentanoate (D-AP5, Tocris, Ellisville, MO, Cat. No. 0106 ), and Dizocilpine ((+)-MK801 ...
-
bioRxiv - Neuroscience 2023Quote: ... NMDAR antagonist D-(-)-2-Amino-5-phosphonopentanoic acid (D-APV 50µM, Tocris-0106) and tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2022Quote: ... and PACAP(6-38) (Tocris). For high K+ stimulation ...
-
bioRxiv - Neuroscience 2022Quote: ... and 6-OHDA (2547, Tocris) were injected into the left hemisphere of substantia nigra pars compacta (SNpc ...
-
bioRxiv - Neuroscience 2023Quote: ... 6-OHDA hydrobromide (Tocris Bioscience) was dissolved in ice-cold 0.02% ascorbic acid dissolved in saline to a concentration of 4 μg/μl ...
-
bioRxiv - Developmental Biology 2022Quote: ... 10 μM TGF-β inhibitor SB431542 (Tocris, Cat. 1614), and 10 μM of prednisolone (Sigma-Aldrich ...